Effects of ulapualide A and synthetic macrolide analogues on actin dynamics and gene regulation |
| |
Authors: | E. Vincent J. Saxton C. Baker-Glenn I. Moal J. D. Hirst G. Pattenden P. E. Shaw |
| |
Affiliation: | (1) Centre for Biochemistry and Cell Biology, School of Biomedical Sciences, University of Nottingham, Queen’s Medical Centre, Nottingham, NG7 2UH, UK;(2) School of Chemistry, University Park, Nottingham, NG7 2RD, UK;(3) Present address: Department of Biochemistry, University of Bristol, Bristol, BS8 1TD, UK |
| |
Abstract: | ![]() Several marine macrolide toxins act as potent and specific actin-severing molecules. Recent elucidation of their stereochemistries and modes of interaction with actin has allowed the syntheses of bioactive analogues. Here we used synthetic analogues in a structure-function analysis of ulapualide A, a trisoxazole-based macrolide. Ulapualide A harboured potent actin-depolymerising activity both in cells and in vitro. Its synthetic diastereoisomer was three orders of magnitude less active than the natural toxin and synthetic macrolide fragments lacked actin-capping/ severing activity altogether. Modulation of serum response factor (SRF)-dependent gene expression, as described for other actin-binding toxins, was also examined. Specific changes in response to ulapualide A were not observed, primarily due to its profound effects on cytoskeletal integrity and cell adhesion. Several synthetic fragments of ulapualide A also had no effect on SRF-dependent gene expression. However, inhibition was observed with a molecule corresponding to the extended aliphatic side chain of halichondramide, a structurally related macrolide. These findings indicate that side-chain derivatives of trisoxazole-based macrolides may serve to uncouple gene-regulatory events from actin dynamics. E. Vincent and J. Saxton: These two authors contributed equally Received 27 September 2006; received after revision 30 November 2006; accepted 8 January 2007 |
| |
Keywords: | |
本文献已被 PubMed SpringerLink 等数据库收录! |
|